Schedule 13G ownership disclosure

ONCOMED PHARMACEUTICALS INC

Security class unavailable · CUSIP: 68234X102

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-096360
Form type
SC 13G/A
Filer
OncoMed Pharmaceuticals Inc
CIK
CIK 1302573
Filed
Feb 12, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub